Prednisolone (PRED) is ineffective in treating adult respiratory distress syndrome (ARDS) (Bernard et al., 1987). ARDS is associated with the generation of superoxide (O2▪-), which negates nitric oxide (NO) bioavailability. In turn, NO down-regulates NADPH oxidase and inhibits O2▪- formation (Muzaffar et al., 2003; 2004). The lack of a therapeutic effect of PRED may be due to an inhibitory effect on the expression of eNOS. In order to test this proposal, the effect of PRED on O2▪- formation and the expression of eNOS and gp91phox (catalytic subunit of NADPH oxidase) in pig pulmonary artery (PA) segments and endothelial cells (PAECs) was investigated. PA segments and PAECs were incubated with PRED and tumour necrosis factor- PRED elicited a concentration-dependent increase in the formation of O2▪- in intact pig pulmonary artery segments (with endothelium) (maximal response at 1 µM PRED; 120 ± 18 nmoles / hr compared t o 25 ± 5 nmoles in controls ) and PAECs (maximal response at 1 µM PRED: 7 ± 0.3 m moles / hr compared to 4 ± 0.7 m moles / hr in controls). PRED (1 µM) -induced increase in O 2 .- release was augmented by Prednisolone increases O2▪- formation in porcine PAECs through an upregulation of NADPH oxidase that is mediated, at least in part, through a down-regulation of eNOS expression. Since the NO-cGMP axis inhibits gp91phox expression, the resultant decrease in endogenous NO formation augments NADPH oxidase activity and therefore O2▪- formation. Since O2▪- promotes inflammation, hypertension and further negation of NO bioavailability, this mechanism may explain, in part, why prednisolone is ineffective in treating ARDS. Thus, the co-administration of an NO donor may render prednisolone more effective in treating ARDS. Bernard, G.R., et al. (1987) N. Engl. J. Med.317: 1565-1570 |